SOUTH SAN FRANCISCO, Calif. — August 14, 2025 — Leads & Copy — Senti Biosciences Inc. (Nasdaq: SNTI) will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech, held virtually from August 19-21, 2025. Timothy Lu, M.D., Ph.D., Senti Bio’s Co-Founder and CEO, will present on Tuesday, August 19, 2025, at 2:20 PM ET.
Senti Bio is a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform. Webull Financial is a leading online brokerage platform empowering self-directed investors with innovative tools and technology.
For more information, visit Senti Bio’s website or follow them on X (@SentiBio) and LinkedIn (Senti Biosciences).
Investor Contact:
JTC Team, LLC
Jenene Thomas
(908) 824-0775
SNTI@jtcir.com
Source: Senti Bio
